Cross-talk between cell adhesion molecules regulates the migration velocity of neutrophils  by Rainger, G.Ed et al.
316 Research Paper
Cross-talk between cell adhesion molecules regulates the
migration velocity of neutrophils
G. Ed Rainger*, Christopher Buckley†, David L.Simmons† and Gerard B. Nash*
Background: Although the adhesive mechanisms underlying the capture and
immobilization of circulating neutrophils in inflamed blood vessels have been well
described, factors controlling the subsequent migration of neutrophils over and
through the blood vessel endothelium are poorly understood. Directional
rearrangement of the actin cytoskeleton within the neutrophil, along with
modulation of integrin-mediated adhesion, are necessary for neutrophil migration.
Signals from chemotactic agents and from the adhesive substrate may regulate
these processes, but little is known about their relative importance or their mode
of integration.
Results: We examined the kinetics of neutrophil migration after formyl tripeptide
or platelet-activating factor was perfused over neutrophils that were already
rolling on the adhesion molecule P-selectin, which was presented either on the
surface of immobilized platelets or in purified form coated on glass capillaries.
Upon activation, neutrophils stopped rolling, spread and began to migrate; each
of these processes was dependent on b2 integrin (CD11b/CD18). The rate of
migration increased over a period of about 8 minutes and was modulated directly
by both the P-selectin and the CD31 surface receptors. Antibody blockade of
either CD31 or P-selectin on platelets resulted in a reduction in the velocity of
migration, and simultaneous blockade of both receptors reduced velocity further.
Purified CD31 and P-selectin (but not a control adhesion molecule, ICAM-1)
increased migration velocity in a concentration-dependent and additive manner
that reconstituted the migratory behaviour observed on platelets.
Conclusions: These studies show that binding of ligands to CD31 and/or 
P-selectin modifies the rate of integrin-supported neutrophil migration. This novel
example of ‘cross-talk’ between surface receptors suggests that cell adhesion
molecules might generally transduce accessory signals between adjacent cells
to modify their migratory responses to chemotactic signals.
Background
During the development of an inflammatory response,
neutrophils are captured from the circulation through a
series of adhesive interactions with the vessel wall that cul-
minate in the migration of the neutrophils into extravascu-
lar tissue [1,2]. Recruitment is initiated with the rolling of
neutrophils on selectins expressed on the endothelial cells
lining the vessel wall, which slows the neutrophils down
and allows the transmission of chemotactic signals from the
endothelium. Neutrophil b2 integrins, activated as a conse-
quence of these chemotactic signals, then mediate station-
ary adhesion by binding to members of the
immunoglobulin superfamily expressed on the endothelial
surface. Activated immobilized platelets can also support
both neutrophil rolling via the expression of P-selectin on
the platelet surface, and neutrophil arrest via interaction of
b2 integrin (CD11b/CD18) expressed on the neutrophil
with an unidentified platelet ligand [3–5]. Although inte-
grin-mediated adhesion appears essential for the onward
migration of neutrophils on endothelial cells or platelets
[4–6], the factors controlling this migration phase are not
well understood.
In general, migration requires directional rearrangement
of the actin cytoskeleton that is the ‘motor’ for locomotion,
along with modulation of integrin-mediated adhesion in
such a way that movement is allowed without the cells
detaching from the surface [7]. Both integrin activation
and actin polymerization are induced in leucocytes by a
range of chemokines and inflammatory agents [8]. In
experimental studies of neutrophil migration over
platelets or immobilized albumin, a continuous supply of
the neutrophil-activating agent (formyl tripeptide,
f–Met–Leu–Phe or fMLP) was required to maintain
attachment, which itself depended on the activation of
newly expressed b2 integrin while existing activated
integrin was downregulated [4,9]. Analogous transient
activation and deactivation of VLA-4 (a4b1 integrin)
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precedes VLA-5 (a5b1 integrin) activation during mono-
cyte migration induced by the chemokine MCP-1 [10].
Thus, triggering of integrins by chemical agents, followed
by regulation of cytoskeletal and integrin activity may be
general strategies to allow sustained cellular adhesion and
migration.
There remains the problem of how direction and rate of
migration are controlled. Neutrophils are capable of
moving preferentially along a concentration gradient of
soluble chemoattractant, and the steepness of such a gra-
dient can affect the rate of migration [11]. Such a gradient
cannot exist, however, in a perfused blood vessel, where
cells might be guided by a haptotactic gradient dependent
on the distribution of a localized adhesion receptor. CD31
is a candidate for this type of regulation of migration,
because binding of ligand to CD31 has been demon-
strated to influence transendothelial migration of neu-
trophils in vitro and in vivo [12,13]. This surface molecule
is expressed by endothelial cells, platelets and leucocytes
and can support cell–cell adhesion via homophilic
CD31–CD31 binding or binding to avb3 integrin [14–16].
Binding of ligand to CD31 also activates b1 and b2 inte-
grins in a number of cells, possibly through signal trans-
duction mediated by homophilic interactions [16–18]. For
natural killer (NK) lymphocytes, antibody-mediated
oligomerization of CD31 induces cytoskeletal rearrange-
ment and integrin-mediated cell-spreading in a process
that is dependent on cAMP [19]. Thus, CD31 ligand-
binding may be hypothesized to influence migration
either by supporting adhesion or by modulating integrin or
cytoskeletal functions.
In this study, we set out to examine how adhesive and
chemokinetic signals were integrated in controlling the
rate of migration of neutrophils over activated platelets or
purified adhesion receptors. Using an in vitro flow-based
assay and time-lapse videomicroscopy, it was possible to
deliver activating agents rapidly to neutrophils already
rolling on platelets or immobilized P-selectin, and to
measure the kinetics of migration immediately thereafter.
Performing the assays under flow conditions also ensured
that agents generated by activated neutrophils themselves
were rapidly washed away (as occurs in vivo), so that we
could directly examine the role of accessory adhesive
mechanisms without the complication of autocrine neu-
trophil responses. We found that binding of ligand to both
CD31 and P-selectin increased the migration rate of
activated neutrophils over platelets, and that these effects
could be reproduced by combining the immobilized
purified receptors. As migration was primarily supported
by CD11b/CD18, our results demonstrate that CD31 and
P-selectin act as accessory signalling molecules to
modulate integrin-mediated migration of neutrophils. In a
general sense, such ‘cross-talk’ between cell-surface
receptors might represent a more important role for some
cell adhesion molecules than their more classical ligand-
binding properties, and might begin to provide a molecu-
lar explanation for the requirement of a number of distinct
cell surface receptors to be engaged for efficient cell
function to occur. 
Results
Rate of neutrophil migration across platelet monolayers
The great majority of adherent neutrophils (> 95%)
perfused over platelet monolayers were rolling and had a
velocity of 1.9 ± 0.15 mm sec–1 (mean ± SEM of 60 cells
from three experiments). After superfusion of fMLP or
platelet-activating factor (PAF), neutrophils stopped rolling
in seconds, spread in 30–60 seconds and migrated over the
luminal surface of the platelet monolayer. Typical paths of
migrating neutrophils are shown in Figure 1. Although
there was fluctuation in velocity with time and also varia-
tion between cells, a marked acceleration phase was
evident when the velocity of a number of neutrophils was
averaged at 1 minute intervals after stimulation with fMLP
or PAF (Fig. 2). Migration started at 2–4 mm min–1 and
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Figure 1
(a) Outlines of 10 neutrophils migrating over immobilized platelets
after activation with fMLP, traced from video records at 1 min intervals.
The mean velocity of the cells increased from approximately 4 to
11 mm min–1 between 1 and 8 min after activation (p < 0.01 by
analysis of variance, ANOVA). (b) Outlines of a single neutrophil from
the above experiment with distance migrated per min in mm
superimposed.
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reached a maximum of approximately 12 mm min–1 after
about 8 minutes of stimulation with either agent. The
migration velocity was constant after this period. The
average migration velocity between 2 and 10 minutes of
chemotactic stimulation was 10.0 ± 1.1 mm min–1 for
fMLP and 9.6 ± 0.8 mm min–1 for PAF (mean ± SEM of 60
cells from three comparative experiments).
Role of adhesion molecules in migration over platelets
We used a panel of antibodies against platelet and
neutrophil adhesion molecules to investigate mechanisms
of migration induced by fMLP. When neutrophils were
treated with anti-CD18 monoclonal antibody (R6.5E),
included with superfused fMLP, rolling adhesion was
maintained after activation and greater than 90% of the
cells gradually detached from the platelet surface as previ-
ously described [4]. Thus, b2 integrins are essential for
firm adhesion and migration of activated cells. Table 1
lists other antibodies used, their specificity and their
effect on the mean rate of migration between 2 and 10
minutes of fMLP stimulation. Pretreatment of neutrophils
with function-blocking antibodies against L-selectin,
CD11a, ICAM-1, ICAM-3 or av integrin (which inhibits
binding to CD31 [14]) did not alter migration velocity.
Thus, these neutrophil-borne receptors have no evident
role in regulating migration velocity across the luminal
surface of platelet monolayers.
When neutrophils and platelets, or platelets alone were
treated with antibody that blocked homophilic CD31
binding, we observed that the mean migration velocity
was significantly reduced (Table 1). Thus, although
homophilic binding of platelet CD31 with neutrophil
CD31 modulated migration velocity, interaction between
CD31 and avb3 integrin did not. The perfusion of
polyclonal antibody against P-selectin along with fMLP,
or pretreatment of platelets with monoclonal anti-P-
selectin antibody G1 significantly reduced the mean
velocity of migration, but control antibodies had no effect
(Table 1). Interaction of P-selectin with its neutrophil
ligand thus appears to modulate the migration response,
along with CD31. We therefore tested the outcome of a
simultaneous blockade of platelet P-selectin and CD31 on
migration rate, and found that the antibodies had additive
effects (Table 1).
More detailed analysis of the migratory velocity of
neutrophils at 1 minute intervals after stimulation with
fMLP is shown in Figure 3, in the presence of antibodies
against CD31, P-selectin or a combination of both. It is
notable that migration started at a similar velocity and that
acceleration occurred for each treatment, but that the anti-
bodies decreased the rate of acceleration and hence the
final velocity. The data for the average migration velocity
from 2 to 10 minutes, as shown in Table 1, therefore rep-
resent a conservative estimate of the final effect of anti-
bodies on migration rate. Control antibodies and the
anti-adhesive antibodies that did not influence migration
rate (Table 1) all gave curves for velocity against time that
were close to those for untreated cells, with a marked
acceleration from a slow start (for example, see Fig. 3 for
monoclonal antibody 10B8). 
Figure 2
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Migration velocity of neutrophils measured at 1 min intervals on
different surfaces. (a,b) Migration of neutrophils on immobilized
platelets after activation with fMLP (10–7 M) and PAF (10–7 M),
respectively. (c,d) Migration of neutrophils on 5 mg ml–1 immobilized
purified P-selectin after activation with fMLP and PAF, respectively.
Data are mean ± SEM for 60 cells from three experiments. ANOVA
showed a significant effect of time on migration velocity for all
conditions (p < 0.01), but no significant difference between the
conditions.
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Neutrophil migration on purified P-selectin and CD31
For immobilized purified P-selectin (at 5 mg ml–1), the
migration responses of neutrophils after activation with
fMLP or PAF (Fig. 2c,d) were indistinguishable from
those on platelets (Fig. 2a,b) and average migration veloci-
ties were 10.6 ± 0.8 or 10.8 ± 0.9 mm min–1, respectively
(mean ± SEM of 60 cells from three comparative experi-
ments; data are not significantly different from the values
for migration over the platelet surface). However, when
comparing migration of neutrophils on purified P-selectin,
CD31 or albumin alone as a control, it was evident that
migration rate was dependent on the receptor density
(Fig. 4). Albumin-coated microslides supported a mean
rate of neutrophil migration over 2 to 10 minutes of about
6.5 mm min–1. Addition of P-selectin or CD31 at increas-
ing concentration caused a significant, dose-dependent
increase in mean migration velocity with maximum of
approximately 12 mm min–1 at a concentration of 5 mg ml–1
for either receptor (Fig. 4a,b). Increasing the concentra-
tion of CD31 or P-selectin to 10 mg ml–1 did not increase
migration velocity further (data not shown). To mimic
migration over platelets, 2.5 mg ml–1 P-selectin and
2.5 mg ml–1 CD31 were used in combination to coat the
same microslide. A significant increase in migration
velocity was evident when both receptors were present
compared with either alone (Fig. 4c). We used purified
ICAM-1 to test whether modulation of migration velocity
was a specific function of P-selectin and CD31. When
ICAM-1 was immobilized on microslides using concentra-
tions of 1 or 10 mg ml–1, migration velocities were 6.7 ± 0.7
and 6.9 ± 0.9 mm min–1, and were not significantly differ-
ent from the velocity on albumin alone (6.9 ± 1.2; all data
are mean ± SEM from three experiments). Figure 5 shows
the migratory velocity of neutrophils at 1 minute intervals
after stimulation with fMLP on ICAM-1, albumin or
CD31/P-selectin mixture. Again, all surfaces allowed an
acceleration of migration for up to approximately 6–7
minutes. Interestingly, albumin and ICAM-1 sustained
migration rates equivalent to those observed on platelet
monolayers after both CD31 and P-selectin had been
blocked with antibodies (Fig. 3).
We used antibodies labelled with radioactive iodine to test
how the levels of purified proteins immobilized on
microslides increased with the coating concentration used,
and to see whether levels were physiologically relevant.
Increasing amounts of antibody were bound as the
Figure 3
Effect of antibody blockade on migration velocity measured at 1 min
intervals for neutrophils migrating on immobilized platelets. Data are
mean ± SEM for 60 cells from three experiments. Error bars for the
individual antibody treatments are not shown for clarity, but error bars
from other treatments are representative. ANOVA showed that there
was a significant effect of time on migration velocity for all treatments
(p < 0.01), and that velocity after treatment with individual blocking
antibodies was significantly different from velocity without treatment
(p < 0.01). ANOVA also showed that the effects of individual blocking
antibodies did not differ, but that their combination produced different
effects from the individual antibodies (p < 0.01).
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Table 1
Effects of antibodies on the migration velocity of neutrophils
adherent to a platelet monolayer.
Antibody target (cell) Antibody Concentration Mean migration
(mg ml–1) velocity
(mm min–1)
Untreated – – 9.7 ± 0.3
L-selectin (N) Leu-8 1 9.6 ± 0.3
CD11a (N) DA36 14 9.1 ± 0.5
ICAM-1 (N) 15.2 10 9.4 ± 0.5
ICAM-3 (N) Cal 3.10 + A041 10 + 10 9.1 ± 0.8
av integrin (N) L230 18 8.8 ± 0.2
CD31 (N & P) L133.1 10 7.0 ± 0.4*
CD31 (N & P) A082 10 6.9 ± 0.2†
CD31 (P) A082 10 7.3 ± 0.3*
P-selectin (P) G1 50 8.0 ± 0.4*
P-selectin (P) RP 20 7.0 ± 0.2†
CD31 + P-selectin (P) A082 + RP 10 + 20 5.4 ± 0.5*
Non-blocking controls:
ICAM-3 (N) Cal 3.3 10 9.3 ± 0.4
CD31 (N & P) 9G11 10 10.4 ± 0.6
CD31 (N & P) 10B8 10 9.5 ± 0.6
P-selectin (P) S12 50 10.1 ± 0.4
Rabbit polyclonal (P) X0903 20 9.4 ± 0.9
Neutrophils and/or platelets were treated with antibodies for 15 min
before assaying migration velocity, except in the case of the rabbit
polyclonal antibody against P-selectin (RP), which was perfused with
fMLP. The migration velocity shown is the average in the period 2—10
min. Data are mean ± SEM from 3–8 experiments. * denotes p < 0.05;
† denotes p < 0.01 compared with untreated cells by paired t test. (N)
or (P) indicate that neutrophils or platelets were treated with antibody.
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concentrations of CD31, P-selectin or ICAM-1 were raised
(Fig. 6). Furthermore, the levels of CD31 (11.4 pg mm–2
bound antibody) and P-selectin (109.1 pg mm–2 bound
antibody) on platelet monolayers were equivalent to those
when approximately 2.5–3.5 mg ml–1 of the purified
proteins were used to coat microslides (Fig. 6a,b).
Discussion
We have demonstrated for the first time that when
neutrophils migrate over the surface of immobilized
platelets or adhesion receptors, there is a distinct accelera-
tion phase lasting for about 8 minutes after the delivery of
an activating agent, and that the acceleration and final
velocity of the neutrophils are dependent on the adhesive
substrate. More specifically, we have shown that P-
selectin and CD31 have complementary abilities to regu-
late the rate of migration supported by b2 integrin, as
revealed by the effects of antibody blockade of the recep-
tors on immobilized platelets, and by studies using the
purified receptors coimmobilized with albumin. Purified
ICAM-1 had no such regulatory ability.
Acceleration of migration was demonstrated by the use of
a flow system that allowed us to follow the early responses
of neutrophils to fMLP or PAF. We are not aware of a pre-
vious description of such early responses, although the
final migration velocities that we obtained by this method
are consistent with those previously measured, for
instance in Zigmond chambers [20]. Maher et al. [11]
demonstrated that the measured velocity of migration
depended on the increments of time over which displace-
ments were measured, because short-term rapid move-
ments were not all in the same direction, and so produced
a lower average value over a prolonged period. For 1
minute intervals (as used here), neutrophils adherent to
albumin moved with a mean velocity of 7.4 mm min–1, but
application of a gradient of fMLP across the cells
increased velocity to 10–20 mm min–1, depending on the
steepness of the gradient [11]. Migration velocity of
neutrophils has also been shown to vary with temperature
and pH [21], but has not been shown previously to vary as
Figure 4
Average migration velocity of neutrophils
2–10 min after activation with fMLP (10–7 M)
on different immobilized proteins at various
concentrations. (a) Albumin alone (Alb) or in
combination with P-selectin; (b) albumin alone
or in combination with CD31; (c) albumin
alone or in combination with P-selectin (P-sel)
and/or CD31 at 2.5 mg ml–1. Data are
mean ± SEM of three experiments. ANOVA
showed a significant effect of concentration
for P-selectin or CD31, and for individual
compared to coimmobilized receptors (all
p < 0.01); * p < 0.05, † p < 0.01 compared to
albumin alone by paired t test. ‡p < 0.01 for P-
selectin and CD31 alone compared to the
combination by paired t test.
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Figure 5
Migration velocity measured at 1 min intervals for neutrophils migrating
on immobilized albumin (1%); albumin (1%) with purified P-
selectin/CD31 mixture (2.5 mg ml–1 of each); or albumin (1%) with
ICAM-1 (10 mg ml–1). Data are mean ± SEM for 60 cells from three
experiments. Error bars for albumin are not shown, for clarity, but error
bars from ICAM-1 are representative. ANOVA showed that there was a
significant effect of time on velocity for all treatments (p < 0.01), and
that velocity on P-selectin/CD31 differed from velocity on albumin
alone or with ICAM-1 (p < 0.01), but that velocities on albumin and
ICAM-1 did not differ.
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a function of interaction with specific receptors. Comparable
velocities to those reported here were found for neutrophils
adhering via b2 integrin(s) to cultured endothelial cells;
average migratory velocity was 12 mm min–1 about
10 minutes after stimulation with fMLP [22].
P-selectin presented either by immobilized, activated
platelets or in purified form, supported rolling adhesion of
neutrophils until they were activated, in agreement with
previous studies [4,23]. Here, anti-CD18 monoclonal anti-
body inhibited the conversion from rolling adhesion to sta-
tionary adhesion on platelets and abolished subsequent
migration, consistent with earlier reports that
CD11b/CD18 mediated these phenomena [4,5]. Blocking
CD11a had no effect on stopping or migration phases
here, again as previously noted [4,5]. We previously found
that the initial stopping phase was due to activation of
constitutively expressed CD11b/CD18, whereas pro-
longed adhesion was dependent upon a switch to newly
expressed integrin [4]. Continual upregulation of
CD11b/CD18 has also been shown to be necessary for
prolonged attachment and neutrophil migration on
albumin-coated surfaces [9]. It seems, therefore, that regu-
lated adhesion via CD11b/CD18 underlies migration of
neutrophils in our models. It is also notable that the kinet-
ics of neutrophil acceleration described here resemble the
time-course of de novo expression of CD11b/CD18 and the
loss of adhesion of activated constitutively expressed
CD11b/CD18 previously demonstrated [4], suggesting
that velocity may be dependent on turnover of this
adhesion molecule. The other major factor likely to
control rate of migration is the polymerization and redistri-
bution of cytoplasmic and cytoskeletal-associated actin
which is required for locomotion [7,24]. Thus, the acces-
sory signals generated by ligation of P-selectin and CD31
probably regulate the function of CD11b/CD18 and/or of
cytoskeletal actin.
P-selectin and CD31 acted to regulate the rate of neutrophil
migration in an additive but independent manner: the
velocity of migration on platelets was reduced by antibodies
against either receptor, and the inhibitory effects of the indi-
vidual interventions were additive; the velocity of migration
on purified P-selectin or CD31 also increased in a concen-
tration-dependent manner, and an additive increase was
found if the two were combined at suboptimal concentra-
tions. An acceleratory phase was manifest for all surfaces,
with or without antibodies. We thus advance the hypothesis
that neutrophils can accelerate to a certain velocity
(~6 mm min–1 in this study) without auxiliary signals, but
that signals transduced by the interactions of P-selectin
and/or CD31 with their neutrophil counterligands amplify
the acceleration so that a greater maximum velocity is
achieved. Amplification might act, for example, by increas-
ing the integrin turnover or actin assembly described above,
or by altering the avidity of integrins for substrate [7].
Although increased or decreased adhesive avidity per se
might explain changes in the rate of migration without the
need to invoke signalling, this does not seem to explain the
action of P-selectin or CD31 in these studies. When ICAM-
1 was immobilized with albumin, increased binding of b2
integrins was evidenced by a 2.5-fold increase in the
number of adherent neutrophils (mean of two experiments;
others showed qualitatively similar effect), but migration
velocity was unchanged. Nor can competitive loss of avidity
induced by colocalization of CD31 and/or P-selectin explain
the increase in velocity: binding of neutrophils to albumin
was unaltered by colocalization of CD31 (data not shown);
in addition, binding to P-selectin is known to be impaired
over minutes following neutrophil activation [25], so that if
the mechanism was one of altered traction, neutrophils
should have reverted to their velocity on albumin with time.
Thus, we conclude that the binding of ligands to CD31 and
P-selectin acts to modulate the migration supported by
CD11b/CD18, rather than to support migration directly.
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Figure 6
Variation in the binding of radio-iodinated
antibodies to immobilized purified receptors
with increasing concentration of receptor. (a)
Monoclonal antibody 9G11 binding to CD31;
(b) rabbit polyclonal antibodies binding to P-
selectin; (c) monoclonal antibody 15.2
binding to ICAM-1. Data are from a single
experiment. Dotted lines represent binding
levels on immobilized platelets for the same
antibodies in matched experiments, with the
equivalent concentration of purified receptor
marked.
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In the case of P-selectin, transduction of a signal to
neutrophils is presumably via the membrane glycoprotein
PSGL-1, which bears sialylated sugars that are recognized
specifically by this receptor [26]. PSGL-1 has been demon-
strated to mediate the rolling of neutrophils on transfectants
bearing P-selectin [27], and we have found that anti-serum
to PSGL-1 ablates adhesion of flowing neutrophils to
platelets (unpublished observations). Signalling via interac-
tion of P-selectin with its ligand is a novel observation for
neutrophils, although both binding of P-selectin to mono-
cytes in suspension [28] and the interaction of PSGL-1 on
monocytes with platelet-borne P-selectin [29] enhance the
response to subsequent activating stimuli. Upon neutrophil
activation, membrane distribution of PSGL-1 is altered at
the same time as the loss of adhesive function noted above
[25]. In the current model, the P-selectin–PSGL-1 interac-
tion appeared to influence migration velocity for at least
10 minutes after cell activation, so that loss of adhesive
function of PSGL-1 might not be synonymous with loss of
signalling function, or alternatively, a signal transduced at
an early stage of migration might have had a lasting effect.
In the case of CD31, only homophilic interactions
modulated neutrophil migration velocity. Blockade of an
alternative ligand (avb3 integrin) had no effect. CD31 has
previously been demonstrated to regulate the activity of b1
or b2 integrins on a number of cells, including neutrophils
[16–18], by a process involving the mobilization of cAMP
[19]. In addition, CD31-mediated contact between trans-
fected cells in a wound-healing assay modulates their
migration velocity [30]. The ability of CD31 to regulate
migration rate is thus consistent with previous demonstra-
tions of its signalling capacity, and with findings that anti-
body blockade inhibits migration of neutrophils through
endothelium and its underlying matrix [12,13]. The impli-
cation of our studies is that inhibition occurs via reduction
in the migration rate or modulation of a linked function
rather than by the blockade of adhesive capability per se.
Conclusions
Our findings indicate that the migration velocity of
neutrophils is dependent on interactions with surface
receptors that do not primarily support attachment itself,
and enable us to propose a model that unifies signals from
chemotactic agents and cell adhesion molecules (Fig. 7).
After activation, b2 integrins engage their counter-receptor,
and the cytoskeletal motor of actin polymerization is upreg-
ulated along with the turnover of CD11b/CD18 (both in the
sense of surface expression and of activation/deactivation) to
drive and support neutrophil migration. Although a basal
rate of migration is achieved on ‘neutral’ surfaces without
‘auxiliary’ receptors, additional ligation of P-selectin
transduces information into the cell modulating a rate-
determining step, such as cytoskeletal actin polymerization
or integrin turnover, in turn increasing the velocity of
neutrophil movement. Signalling might act, for instance,
through modulation of cytoplasmic Ca2+, which is known to
be able concurrently to regulate cytoskeletal rearrangement,
integrin function and neutrophil motility [31]. The presence
of CD31 on the adhesive substrate operates to increase
migration in a similar manner by engaging neutrophil CD31.
When both P-selectin and CD31 are present on the
adhesive substrate, they simultaneously transduce
information into the cell, and further increase the
migration velocity.
In general, neutrophil migration requires spatial and
temporal coordination of responses to a range of cues from
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Figure 7
(c) Binding of P-selectin and CD31
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Model of the modulation of neutrophil migration rate. (a) Upon
activation by fMLP, neutrophil CD11b/CD18 engages a counterligand
and supports migration which accelerates up to a limiting rate
dependent on the cytoskeletal motor of actin polymerization, and on
turnover of CD11b/CD18 (cyclic activation and deactivation combined
with de novo expression). Integrin activation itself may be modulated
by interaction with the actin cytoskeleton. (b) An activated neutrophil
binds P-selectin on the substrate via PSGL-1, which transduces
information into the cell resulting in increased activity of the
cytoskeletal motor and/or turnover of CD11b/CD18; migration velocity
is increased. (c) An activated neutrophil binds both P-selectin and
CD31 on the substrate via PSGL-1 and CD31, respectively, which
transduce information into the cell resulting in additive increase in
activity of the cytoskeletal motor and/or CD11b/CD18 turnover;
migration velocity is further increased. 
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chemical signals (such as PAF and bacterial peptides, in
suspension or presented on a surface), and from adhesion
molecules that not only support neutrophil attachment
but may also act to modify responses to signals [7,26].
Here, we have identified a novel form of cross-talk
between adhesion receptors that modulates the rate of
migration of neutrophils over platelets or purified recep-
tors. Whereas platelets might support all stages of neu-
trophil capture and migration on a damaged vessel wall
[3,5], regulation of migration by this route should also
apply for endothelial cells that are able to present the
same receptors [1,2]. Thus, adhesive cross-talk may be an
important factor in modulating the migration of neu-
trophils into tissue in a wide range of conditions. Our
results also support the general concept that the function
of ‘adhesion molecules’ may not always be to provide
mechanical support but might also be to regulate func-
tions such as motility. This proposal might explain why
efficient cell function may require engagement of a
number of distinct cell surface receptors that are not
obviously needed for anchorage.
Materials and Methods
Antibodies
All monoclonal antibodies were isotype IgG1 unless otherwise stated.
Monoclonal antibodies R6.5E (against CD18) and DA36 (against
CD11a) were gifts of Martyn Robinson (Celltech); 15.2 (against ICAM-
1) was a gift from Nancy Hogg (ICRF); Leu-8 (against L-selectin) was
from Becton Dickinson. Monoclonal antibodies against CD31 were the
function-blocking L133.1, recognizing domain 2 (Becton Dickinson),
and 7E4, recognizing domain 3 (designated A082, from the 6th Inter-
national CD Antigen Workshop; isotype IgG2), and non-blocking con-
trols, 10B8, recognizing domain 5 (gift of Ian Collins, R and D
Systems), and 9G11, recognizing domain 1 [16]. The monoclonal anti-
body against av-integrin was L230 (ATCC), which blocked interaction
with CD31 [14]. Monoclonal antibodies against P-selectin were G1
(adhesion blocking) and S12 (non-blocking) and were gifts from
Rodger McEver (University of Oklahoma). Rabbit polyclonal anti-P-
selectin was a gift of Michael Berndt (Baker Medical Research Insti-
tute). Non-specific rabbit polyclonal X0903 was from Dako.
Monoclonal antibodies against ICAM-3 were Cal 3.10 and Cal 3.3 [32]
and 186-269 (designated A041 from the 6th International CD Antigen
Workshop; isotype IgG2).
Neutrophil isolation 
Blood for neutrophil preparation was collected from normal volunteers
into citrate phosphate dextrose adenine-1 (CPDA-1; Baxter Health
Care). Neutrophils were separated using two-step density gradients of
Histopaque (Sigma) as described previously [3,4]. Cells were washed,
counted by Coulter counter (Coulter Electronics) and adjusted to
1 × 106 ml–1 in 0.1% bovine serum albumin (BSA, fraction IV; Sigma) in
phosphate buffered saline containing 1 mM Ca2+ and 0.5 mM Mg2+
(PBS; Sigma)
Immobilization of platelet monolayers in microslides
Microslides (Cam Lab) are glass capillary tubes with a rectangular
cross-section of 0.3 × 3 mm, a length of 5 cm and good optical quali-
ties. In order to provide a substrate that readily binds platelets,
microslides were coated with 3-aminopropyltriethoxysilane (APES;
Sigma) as previously described [3]. Blood for platelet preparation
was collected into sodium heparin (CP Pharmaceuticals). Platelet-
rich plasma (PRP) was derived by spinning the blood at 300 × g for
5 min and removing the platelet-rich supernatant. Platelets were
counted, adjusted to 2 × 108 ml–1 with PBS, loaded into microslides
and incubated at room temperature for 40 min to allow them to sedi-
ment, adhere and form a confluent monolayer [3]. Unbound platelets
were removed by washing prior to assay. Experiments were always
conducted using autologous platelets and neutrophils.
Immobilization of purified adhesion receptors in microslides
and quantitation of surface density
Affinity-purified recombinant P-selectin, CD31 or ICAM-1 (all produced
from stably transfected CHO cells; gift of Ian Collins, R and D
Systems) were dissolved in PBS in the range 1–10 mg ml–1. The pro-
teins were immobilized by incubating the desired concentration in an
APES-treated microslide for 60 min at 37°C. Free protein-binding sites
were blocked with 1% BSA for 60 min at 37°C. In some experiments,
mixtures of proteins were coincubated for 60 min at 37°C followed by
blocking with 1% BSA. To quantify the concentration of purified protein
that was immobilized, chosen antibodies were radio-iodinated and the
specific activity of antibody bound to increasing concentrations of
immobilized adhesion receptors was measured. The anti-CD31 mono-
clonal antibody 9G11, the anti-ICAM-1 monoclonal antibody 15.2 and
rabbit anti-P-selectin polyclonal antibody (RP) were aliquoted in reac-
tion tubes in volumes of 10 ml at a final concentration of 1 mg ml–1,
1 mg ml–1 and 0.42 mg ml–1 respectively. 50 ml of 0.25 M phosphate
buffer pH 7.5, 5 ml of Na125I (100 mCi ml–1; Amersham) and 10 ml of
Chloramine-T (0.56 mg ml–1) were added and incubated at room tem-
perature for 1 min. The reaction was quenched by the addition of
100 ml of tyrosine solution (1 mg ml–1 in 50 mM phosphate buffer,
pH 7.5). Antibodies were recovered and purified by passage down a
Sephadex P.D. 10 column (Pharmacia). Activity of the iodinated anti-
bodies (counts min–1) was measured on a scintillation counter and con-
verted to counts min–1 g–1 of antibody assuming a 75% recovery of the
antibody loaded onto columns. Microslides coated with purified pro-
teins were incubated with iodinated antibodies at concentrations of
7.5 mg ml–1 for 15.2, 5.0 mg ml–1 for 9G11 and 3.2 mg ml–1 for RP, for
45 min at room temperature. Unbound antibody was removed with
thorough washing in 0.1% BSA/PBS. Activity per microslide was mea-
sured by scintillation counter and was converted to pg of
antibody mm–2 of microslide surface after subtraction of counts from
antibody-treated albumin-coated control microslides. Determination of
antibody binding to CD31 and P-selectin on the surface of platelets
was carried out in an identical manner using microslides containing
confluent platelet monolayers.
Adhesion and migration under conditions of flow 
The adhesion assay was based on that recently described [4].
Microslides containing confluent platelet monolayers or purified adhe-
sion receptors were attached to a Harvard syringe pump by means of
flexible silicon tubing, and cell-free buffer or a suspension of neu-
trophils was drawn through the microslides using a microelectronic
switching valve (Lee Products). A constant wall shear stress (0.05 Pa
unless otherwise stated) was maintained in the microslide by choice of
the appropriate flow rate. This equates to 0.5 dyn cm–2 and is at the
low end of the physiological range of wall shear stress in post-capillary
venules [33]. This stress was chosen so that large numbers of adher-
ent neutrophils could be established, and to conserve perfused
reagents and cells. In limited experiments, we verified that migration
proceeded essentially unaltered at 0.1 and 0.2 Pa. Microslides were
mounted on the stage of a microscope fitted with a video camera,
monitor and recorder. For experiments in which selectins were present
on the microslide surface (that is, platelet monolayers or purified P-
selectin), neutrophil suspension was flowed over the adhesive sub-
strate for 5 min to establish a large number (~1500 mm–2) of
continuously rolling cells. Nonadherent cells were washed from the
microslide by perfusing cell-free buffer (0.1% BSA in PBS) for 2 min. A
video record was made in at least five fields of view to allow the
number of adherent cells to be counted off-line and their rolling behav-
iour to be analyzed [3]. Rolling neutrophils were then activated on the
adhesive surface by the continuous perfusion of either fMLP (10–7 M)
or PAF (10–7 M). Upon exposure to chemotactic stimuli, neutrophils
stopped rolling , underwent shape change and spread on the platelet
surface [4]. After the initial period of spreading, neutrophils began to
migrate across the platelet surface. The migratory response was then
analyzed. A single field of rolling neutrophils (containing approximately
150 cells) was chosen and the response to chemotactic stimulation
recorded by time-lapse videomicroscopy (using a 9-fold time conden-
sation) for a duration of 10 min. The rate of migration was assessed off
line. The outlines of 10 cells were traced onto acetate sheets overlying
the video monitor. This process was repeated as the video record was
moved forward in 1 min intervals for a total of 10 min (Fig. 1). The
screen size was calibrated using a stage micrometer and the move-
ments of individual cells converted to migratory velocity in mm min–1 by
measuring the distance advanced by the leading cellular margin (Fig.
1b). When selectins were not present on the microslide (purified
ICAM-1, CD31 or albumin alone), there was no rolling adhesion, so
that it was necessary to activate neutrophils with fMLP (10–7 M) imme-
diately prior to perfusion. To allow the direct adhesion of flowing neu-
trophils via activated integrins, low wall shear stress (0.0125 Pa) was
applied for 1.5 min of cell perfusion. The wall shear stress was then
returned to 0.05 Pa and a continuous video record of migration made
from exactly 2 min after initial activation. In this way, we were able to
follow migration from 2 to 10 min after activation. Migratory velocities
were analyzed as before.
Antibody interventions
Table 1 lists the antibodies used, their specificity, and working con-
centration. Neutrophils were treated with antibody for 15 min at room
temperature before perfusion. Microslides containing confluent
monolayers of platelets were treated with the relevant antibody for
15 min at room temperature prior to neutrophil perfusion. Platelet P-
selectin was blocked in two manners: polyclonal antibody was per-
fused with fMLP over rolling neutrophils because pre-treatment of
platelets abolished adhesion; platelets were pre-treated with mono-
clonal antibody (which was only available in smaller quantity) and pre-
activated neutrophils perfused at low stress to allow attachment as
described above for purified CD31. Blockade of ICAM-3 function
was achieved by treating neutrophils with a combination of A041 and
Cal 3.10 as previously described [32]. The molecular basis for such a
blocking regime is not clearly understood but the individual antibod-
ies are not functionally effective.
Statistics
Concurrent effects of time and different treatment group were tested
using two-way analysis of variance (ANOVA), followed by one-way
ANOVA for effect of time on a single treatment where appropriate.
Comparison of individual treatments or conditions at single time
points were made by paired t test or unpaired (Student’s) t test as
appropriate.
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